Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 1 feed behind: Insider filings, 3 days · Every feed →

More filters
Clear filters

Insiders · buys only · 8,854 trades

Trades
8,854
Buys 8,854 · Sells 0
People
2,363
Stocks
1,234
Disclosed value
$11.5B
range midpoints · Congress & executive
Filed late
1,178
  1. ▲ BUYJack Jiajia Huang Chief Executive OfficerCOE 51Talk Online Education Group$364Kdisclosed Jun 10 · filed 6 days after the trade · late
  2. ▲ BUYBrian Niranjan Sheth DirectorBLND Blend Labs, Inc.$304Kdisclosed Jun 10 · filed 1 day after the trade
  3. ▲ BUYJoseph R Nerges 10% ownerCSPI Csp Inc$1.6Kdisclosed Jun 10 · filed 1 day after the trade
  4. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late
  5. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$44.9Kdisclosed Jun 10 · filed 2 days after the trade
  6. ▲ BUYHaveli Investments Software Fund I GP, LLC DirectorBLND Blend Labs, Inc.$304Kdisclosed Jun 10 · filed 1 day after the trade
  7. ▲ BUYJoseph Fralin Woody DirectorRCEL AVITA Medical, Inc.$20.8Kdisclosed Jun 10 · filed 1 day after the trade
  8. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  9. ▲ BUYHaveli Brooks Aggregator, L.P. DirectorBLND Blend Labs, Inc.$1.2Mdisclosed Jun 10 · filed the same day
  10. ▲ BUYRussell B Wight Jr DirectorVNO Vornado Realty Trust$17.7Kdisclosed Jun 10 · filed 2 days after the trade
  11. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late
  12. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$5.3Kdisclosed Jun 10 · filed 20 days after the trade · late
  13. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$3.2Kdisclosed Jun 10 · filed 8 days after the trade · late
  14. ▲ BUYThomas J. Allison DirectorHRZN Horizon Technology Finance Corp$26.2Kdisclosed Jun 10 · filed 1 day after the trade
  15. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$1.1Kdisclosed Jun 10 · filed 7 days after the trade · late
  16. ▲ BUYNutter Carol SVP, Chief People OfficerCTEV Claritev Corp$24.9Kdisclosed Jun 10 · filed 1 day after the trade
  17. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$31.5Kdisclosed Jun 10 · filed 8 days after the trade · late
  18. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  19. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$78.4Kdisclosed Jun 10 · filed 5 days after the trade · late
  20. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$9.6Kdisclosed Jun 10 · filed 6 days after the trade · late
  21. ▲ BUYRussell B Wight Jr DirectorVNO Vornado Realty Trust$15Kdisclosed Jun 10 · filed 2 days after the trade
  22. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$970disclosed Jun 10 · filed 6 days after the trade · late
  23. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$4.5Kdisclosed Jun 10 · filed 2 days after the trade
  24. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$3.2Kdisclosed Jun 10 · filed 8 days after the trade · late
  25. ▲ BUYJonathan Joseph Goodman DirectorHRZN Horizon Technology Finance Corp$25.9Kdisclosed Jun 10 · filed 1 day after the trade